Formosa Laboratories Inc (TW:4746) — Market Cap & Net Worth
Market Cap & Net Worth: Formosa Laboratories Inc (4746)
Formosa Laboratories Inc (TW:4746) has a market capitalization of $174.47 Million (NT$5.54 Billion) as of September 17, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #17160 globally and #843 in its home market, demonstrating a -0.75% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Formosa Laboratories Inc's stock price NT$46.05 by its total outstanding shares 120256000 (120.26 Million). Also see Formosa Laboratories Inc assets under control for a full breakdown of the balance sheet.
Formosa Laboratories Inc Market Cap History: 2015 to 2026
Formosa Laboratories Inc's market capitalization history from 2015 to 2026. Data shows change from $225.03 Million to $174.47 Million (-1.17% CAGR). Also see 4746 operating cash flow for how efficiently the company converts equity into cash flow.
Formosa Laboratories Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Formosa Laboratories Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Formosa Laboratories Inc (4746) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.05x
Formosa Laboratories Inc's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.51x
Formosa Laboratories Inc's market cap is 0.51 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $330.75 Million | $3.19 Billion | $483.44 Million | 0.10x | 0.68x |
| 2017 | $238.01 Million | $2.54 Billion | $238.65 Million | 0.09x | 1.00x |
| 2018 | $137.23 Million | $2.69 Billion | $176.82 Million | 0.05x | 0.78x |
| 2019 | $152.01 Million | $2.76 Billion | -$41.06 Million | 0.06x | N/A |
| 2020 | $170.53 Million | $3.08 Billion | $400.03 Million | 0.06x | 0.43x |
| 2021 | $219.75 Million | $3.14 Billion | $1.25 Billion | 0.07x | 0.18x |
| 2022 | $278.47 Million | $3.77 Billion | $216.81 Million | 0.07x | 1.28x |
| 2023 | $386.45 Million | $4.36 Billion | $126.24 Million | 0.09x | 3.06x |
| 2024 | $260.66 Million | $4.73 Billion | $157.27 Million | 0.06x | 1.66x |
| 2025 | $224.67 Million | $4.85 Billion | $441.11 Million | 0.05x | 0.51x |
Competitor Companies of 4746 by Market Capitalization
Companies near Formosa Laboratories Inc in the global market cap rankings as of September 17, 2026. Review Formosa Laboratories Inc tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Formosa Laboratories Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Formosa Laboratories Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Formosa Laboratories Inc's market cap moved from $225.03 Million to $ 174.47 Million, with a yearly change of -1.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$174.47 Million | -22.34% |
| 2025 | NT$224.67 Million | -13.81% |
| 2024 | NT$260.66 Million | -32.55% |
| 2023 | NT$386.45 Million | +38.78% |
| 2022 | NT$278.47 Million | +26.72% |
| 2021 | NT$219.75 Million | +28.86% |
| 2020 | NT$170.53 Million | +12.19% |
| 2019 | NT$152.01 Million | +10.77% |
| 2018 | NT$137.23 Million | -42.34% |
| 2017 | NT$238.01 Million | -28.04% |
| 2016 | NT$330.75 Million | +46.98% |
| 2015 | NT$225.03 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Formosa Laboratories Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $174.47 Million USD |
| MoneyControl | $174.47 Million USD |
| MarketWatch | $174.47 Million USD |
| marketcap.company | $174.47 Million USD |
| Reuters | $174.47 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Formosa Laboratories Inc
Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. It offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomo… Read more